Top compounds associated with response to TMEM199


Feature Type Standardized
Nominal ANOVA
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA momelotinib CTRPv2 pan-cancer AAC -0.044 0.2
mRNA BIRB 0796 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA SN-38 CTRPv2 pan-cancer AAC -0.047 0.2
mRNA Axitinib CTRPv2 pan-cancer AAC -0.043 0.2
mRNA marinopyrrole A CTRPv2 pan-cancer AAC 0.057 0.2
mRNA BRD4132 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA Imatinib CTRPv2 pan-cancer AAC -0.046 0.2
mRNA selumetinib:UNC0638 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC -0.049 0.2
Download CSV